for the TIMI Investigators. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), phase II trial - Bovill, E G; Terrin, M L; Stump, D C; Berke, A D; Frederick, M; Collen, D; Feit, F; Gore, J M; Hillis, L D; Lambrew, C T; Leiboff, R; Man, K G; Markis, J E; Pratt, C M; Sharkey, S W; Sopko, G; Tracy, R P; Chesebro, J H (Ann Int Med, 1991)